CRLF2 defects in Down syndrome-associated leukemia
Nature Genetics
October 19, 2009
A chromosomal alteration that fuses the P2RY8 and CRLF2 genes is found in individuals with B-progenitor acute lymphoblastic leukemia (ALL) and ALL associated with Down syndrome (DS), according to a new study published online this week in Nature Genetics.
ALL is the most common childhood cancer, with a cure rate of 85% in children. Children with DS are approximately 10-20 times more likely to develop leukemia than non-DS children.
Charles Mullighan and colleagues report that a recurrent chromosomal deletion that leads to the P2RY8-CRLF2 fusion is found in 7% of individuals with B-progenitor ALL and 53% of individuals with Down syndrome-associated ALL. The fusion leads to elevated activity of the CRLF2 gene, which may contribute to the increased risk of ALL in children with DS.
doi: 10.1038/ng.469
Research highlights
-
Oct 27
Social science: The ups and downs of social mobility in Great BritainNature Communications
-
Oct 26
Archaeology: Layout of ancient Mesoamerica sites revealed by remote sensingNature Human Behaviour
-
Oct 21
Archaeology: Pinpointing the presence of Vikings in the AmericasNature
-
Oct 21
Genetics: Honing in on the homeland of horsesNature
-
Oct 21
Ecology: The marvellous make-up of the Mammoth SteppeNature
-
Oct 20
Cell biology: Viral glycoproteins may aid spread of protein aggregates associated with neurodegenerative diseasesNature Communications
